UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 0-33169 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 13-4 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | --- | --- | --- | |----------------------------------------------------------------|------------------------------------------------------------------------------------------------ ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q3 2020 Earnings Conference Call November 4, 2020 5:00 PM ET Executives Kevin Clark - CEO Bill Burns - CFO Buffy White - President of Workforce Solutions and Services Steve Saville - EVP, Operations Analysts A.J. Rice - Credit Suisse Jeff Silber - BMO Capital Markets Kevin Fischbeck - Bank of America Brian Tanquilut - Jefferies Kevin Steinke - Barrington Research Operator Good afternoon, ladies and gentlemen, and welcome to the Cross Country Healthcare Earnings C ...

Financial Data and Key Metrics Changes - Consolidated revenue for Q2 2020 was $216.8 million, representing a 7% increase year-over-year and a 3% sequential increase, primarily driven by nearly 1,000 nurses on COVID-related assignments [23][24] - Adjusted EBITDA for the quarter was $11.6 million, supported by higher gross profit and approximately $2 million in realized cost savings [23] - Gross profit was $50.7 million with a gross margin of 23.4%, down 20 basis points sequentially due to the mix of business from COVID assignments [29][30] Business Line Data and Key Metrics Changes - The Nurse and Allied segment reported revenue of $198.1 million, up 10% year-over-year, largely due to COVID-related assignments generating over $30 million in incremental revenue [24][9] - The Physician Staffing segment experienced a revenue decline of 7% sequentially, with a 6% year-over-year decrease, primarily due to reduced elective procedures impacting specialties like anesthesiology [28] - Local branch-based business saw a decline of approximately 12% to 13% both sequentially and year-over-year, although some revenue was offset by COVID-19 crisis orders [25] Market Data and Key Metrics Changes - Demand for healthcare professionals has shown significant volatility, with orders initially rising over 20% and then falling sharply by more than 80% as hospitals faced lower census [7] - Recent increases in orders have been noted in states like California, Texas, and Florida, particularly in ICU and surgical specialties [8] Company Strategy and Development Direction - The company is focused on integrating and optimizing operations, with plans to save over $20 million annually through operational efficiencies and right-sizing teams [13][12] - Technology initiatives, including the rollout of Cross Country Marketplace and a new applicant tracking system, are expected to enhance productivity and efficiency [16][17] Management's Comments on Operating Environment and Future Outlook - Management anticipates a sequential revenue decline of 17% to 22% for Q3 2020 due to the wind-down of premium rate COVID assignments and lower demand for physician business [20][40] - Despite current challenges, management remains optimistic about sequential improvement in revenue and profitability for Q4 2020 as the market recovers [21][22] Other Important Information - The company ended the quarter with $6.2 million in cash and $49.1 million in outstanding debt, with strong cash flow from operations of $16.6 million [37][38] - The company has implemented a cost action plan expected to drive gross savings of $20 million to $22 million annually [33] Q&A Session Summary Question: Market recovery in the Northeast and Midwest - Management noted that while strong demand is currently in the South and West, there are signs of recovery in the Northeast and Northwest, with orders increasing sharply from historic lows [47] Question: Nurse turnover rates post-crisis - Management indicated that there is a tight supply of nurses, with local staffing needs increasing due to fatigue among core staff, leading to higher demand for contingent staffing [49][50] Question: Guidance on crisis-related orders - Management confirmed that year-over-year orders are up significantly, driven by COVID, particularly in critical care and telemetry [55] Question: Focus on MSP customers and pricing dynamics - Management highlighted that their MSP business is at an all-time high, with a capture rate improvement to 65%, but noted that order flow remains volatile [59][60] Question: Future technology upgrades and cost savings - Management discussed ongoing technology initiatives, including a new applicant tracking system and plans for middle office integration, which are expected to enhance efficiency and reduce costs [66][72] Question: Adjusted EBITDA margin target - Management reaffirmed the goal of achieving 8% adjusted EBITDA margins by Q4 2022, driven by increased volume, productivity improvements, and cost reductions [76]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From _________ to _________ ——————— CROSS COUNTRY HEALTHCARE, INC. (Exact name of registrant as specified in its charter) ——————— Delaware 0-33169 13-4066229 (St ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q1 2020 Earnings Conference Call May 7, 2020 5:00 PM ET Company Participants Kevin Clark - President, Chief Executive Officer Bill Burns - Chief Financial Officer Buffy White - President of Workforce Solutions and Services Steve Saville - Executive Vice President of Operations Conference Call Participants A.J. Rice - Credit Suisse Jason Plagman - Jefferies Tobey Sommer - SunTrust Henry Chien - BMO Operator Good evening, ladies and gentlemen, and welcome to the Cr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ——————— FORM 10-Q ——————— ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From _________ to _________ ——————— CROSS COUNTRY HEALTHCARE, INC. (Exact name of registrant as specified in its charter) ——————— Delaware 0-33169 13-4066229 (S ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________ FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 0-33169 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 13-4 ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2019 Earnings Conference Call March 4, 2020 5:00 PM ET Company Representatives Kevin Clark - President, Chief Executive Officer Bill Burns - Chief Financial Officer Buffy White - President of Workforce Solutions and Services Steve Saville - Executive Vice President of Operations Conference Call Participants A.J. Rice - Credit Suisse Jason Plagman - Jefferies Jeffrey Silber - BMO Capital Market Jasper Bibb - SunTrust Kevin Steinke - Barrington Research Bill Sut ...

Financial Data and Key Metrics Changes - Consolidated revenue for Q3 2019 was $209.2 million, up 3% sequentially and up 4% year-over-year, driven predominantly by growth in the Nurse and Allied segment [20][21] - Adjusted EBITDA for the quarter was $7.3 million, exceeding the high end of guidance, largely due to revenue overachievement [25] - Gross profit margin for the quarter was 24.4%, down 130 basis points year-over-year and 100 basis points sequentially, attributed to tightening bill-pay spreads [22] Business Line Data and Key Metrics Changes - Revenue for the Nurse and Allied segment was $185 million, up 2% sequentially and up 5% year-over-year, with broad-based growth across all service lines [21] - Physician Staffing reported revenue of $20.4 million, down 4% year-over-year but up 13% sequentially, driven by increased volume across specialties [22] Market Data and Key Metrics Changes - Demand for travel nursing increased with orders growing 16% sequentially and over 50% year-over-year, attributed to MSP wins and broader market conditions [11] - Spend under management at MSPs increased 8% sequentially and 11% year-over-year, indicating strong market demand [12] Company Strategy and Development Direction - The company aims to become a leading total talent solutions provider, focusing on evolving the go-to-market approach, reinvigorating corporate culture, and digitally transforming operations [12][13] - A strategic goal includes achieving a high single-digit EBITDA margin over the next few years, with a target of reaching 8% profitability [18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about demand levels, particularly in the travel business, expecting sequential growth in most lines despite holiday impacts [17] - The company is encouraged by favorable market conditions, with a significant year-over-year increase in demand [33] Other Important Information - The company successfully refinanced its senior credit facility to a more flexible $120 million asset-based credit facility, enhancing liquidity for operations and acquisitions [27][28] - The company expects to realize gross savings of $12 million to $13 million annually from cost-saving initiatives [23] Q&A Session Summary Question: Timing for achieving 8% EBITDA margin - Management believes achieving a high single-digit EBITDA margin is possible over the next few years, driven by operating leverage and technology investments [32][34] Question: Outlook for winter orders and demand - Orders are up heading into winter, with a supply-constrained marketplace, although initial activity has been slower than previous years [36][37] Question: Willingness of clients to increase rates - There is upward movement in bill rates, with expectations for continued growth due to high demand [40] Question: M&A strategy and target sectors - The company is looking for acquisition opportunities that can improve margins, particularly in Locums, Allied, Education, and Technology sectors [46] Question: Recruiter headcount and productivity - The company has reached a steady state in recruiter headcount, focusing on improving productivity through training and tools [50][51] Question: IT migration timeline - The first pilot of the new applicant tracking system will roll out soon, with broader implementation expected by late spring [56] Question: Trends in existing accounts vs. new accounts - Existing MSPs show a higher capture rate compared to new ones, with strong opportunities for growth in both [59][61]